Features | Partner Sites | Information | LinkXpress
Sign In
Ampronix
Schiller
Demo Company

Imaging for Amyloid Deposits Also Shows Promise for Detecting Cardiac Amyloidosis

By Medimaging International staff writers
Posted on 21 Feb 2013
Whereas amyloid imaging may now be most associated with detecting plaques in the brain, it also has the potential to alter the way cardiac amyloidosis is diagnosed. According to first-of-its-kind research, positron emission tomography (PET) with 11C-PIB (Pittsburgh compound B) can effectively visualize amyloid deposits in the heart. Currently, there is no other noninvasive test available for specific diagnosis.

The study’s findings were published in the February 2013 issue of the Journal of Nuclear Medicine. Cardiac amyloidosis is a deadly disorder caused by abnormal amyloid deposits in the heart tissue. Early diagnosis before structural change to the heart tissue has occurred is important for disease prognosis and for treatment monitoring. Echocardiography is the current mainstay of imaging in cardiac amyloidosis; a cardiac biopsy is used to validate diagnosis.

“Imaging with 11C-PIB provides a noninvasive and specific means of showing distribution of amyloid in an organ. This gives a unique opportunity to follow and monitor therapy, as amyloid deposits in the heart should decrease with successful therapy,” said Gunnar Antoni, PhD, from department of medicinal chemistry, Uppsala University (Sweden), and lead author of the research.

The study included 10 patients diagnosed with cardiac amyloidosis and five healthy individuals. PET/computed tomography (CT) with 11C-PIB was used to visualize amyloid deposits in the heart and with 11C-acetate to measure myocardial blood flow.

Uptake of 11C-PIB was measured 15–25 minutes after injection. Obvious uptake of 11C-PIB was noted in the left ventricle wall of all patients with cardiac amyloidosis, while no uptake was seen in the healthy volunteers. In half of the patients, 11C-PIB was also detected in the right ventricle wall, and nine of the patients had signs of reversible uptake, with a maximum concentration at 10–15 minutes after injection. Myocardial blood flow was significantly lower in patients with cardiac amyloidosis; however, no significant correlation between myocardial blood flow and 11C-PIB uptake was found.

“This study emphasizes the strength of molecular imaging for detecting an underlying and significant molecular aberration in a disease that presents with unspecific symptoms and signs,” noted Dr. Antoni. “The potential for molecular imaging to provide valuable information for other diseases is of great value to the field of medicine.”

Related Links:
Uppsala University






Channels

MRI

view channel
Image: Siemens Healthcare MAGNETOM Avanto 1.5-T MRI Scanner (Photo courtesy of Siemens Healthcare).

MRI Technique Allows for “Fingerprinting” of Tissues and Diseases for Faster Diagnoses

New findings published in the journal Nature indicate that a new Magnetic Resonance Imaging (MRI) technique, called Magnetic Resonance Fingerprinting (MRF), could provide much more information with each... Read more

Ultrasound

view channel

New Ultrasound System Enhances Patient Care and User Experience

A new ultrasound system with innovative specialized transducers and improved image quality, intended for general imaging, women’s health, and shared service applications, has been announced. The system features improved accuracy, performance, assessment tools, advanced automation, and an enhanced user experience.... Read more

General/Advanced Imaging

view channel
Image: Illustration of a new technique using Optical Coherence Tomography that could help surgeons differentiate a human brain tumor, red, from surrounding noncancerous tissue, green (Photo courtesy of  Carmen Kut, Jordina Rincon-Torroella, Xingde Li and Alfredo Quinones-Hinojosa/Johns Hopkins Medicine).

Imaging Technique Helps Safer and More Effective Removal of Brain Tumors

Researchers at the Johns Hopkins University have demonstrated a new imaging technology that could enable neurosurgeons to better differentiate between healthy and cancerous brain tissue and perform safer... Read more

Imaging IT

view channel
Image: Siemens Healthcare’s syngo.via MM Oncology facilitates compliance by clinicians to British Thoracic Society guidelines for the investigation and management of pulmonary nodules.(Photo courtesy of Siemens Healthcare).

Oncology Software Update Compliant with New BTS Guidelines

A key diagnostic imaging vendor has announced that it has modified its oncology software solution to ensure compliance with new British Thoracic Society (BTS) guidelines for lung nodule screening.... Read more

Industry News

view channel

Report Forecasts Growth of Global Computed Tomography Sector to USD 6 billion by 2019

A new report has been published that analyzes global Computed Tomography (CT) market shares, strategies, and forecasts, for the years 2013 to 2018. The report entitled “Global Computed Tomography (CT) Market Shares, Strategies, and Forecasts, 2013 to 2018,” predicts that global CT markets will continue to grow moderately... Read more
 

Events

11 Sep 2015 - 12 Sep 2015
19 Sep 2015 - 24 Sep 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.